Cargando…
The methylation profiles of PRDM promoters in non–small cell lung cancer
BACKGROUND: Non–small cell lung cancer (NSCLC) is one of the leading malignant tumors worldwide. Aberrant gene promoter methylation contributes to NSCLC, and PRDM is a tumor suppressor gene family that possesses histone methyltransferase activity. This study aimed to investigate whether aberrant met...
Autores principales: | Tan, Shuang-xiang, Hu, Rui-cheng, Xia, Qian, Tan, Yong-li, Liu, Jing-jing, Gan, Gui-xiang, Wang, Li-le |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973400/ https://www.ncbi.nlm.nih.gov/pubmed/29872311 http://dx.doi.org/10.2147/OTT.S156775 |
Ejemplares similares
-
PRDM14 Promotes the Migration of Human Non-small Cell Lung Cancer Through Extracellular Matrix Degradation in vitro
por: Bi, Hong-Xia, et al.
Publicado: (2015) -
Downregulation of promoter methylation gene PRDM5 contributes to the development of tumor proliferation and predicts poor prognosis in gastric cancer
por: Teng, Jing-jing, et al.
Publicado: (2021) -
PRDM16 functions as a suppressor of lung adenocarcinoma metastasis
por: Fei, Liang-Ru, et al.
Publicado: (2019) -
DNA methylation in PRDM8 is indicative for dyskeratosis congenita
por: Weidner, Carola I., et al.
Publicado: (2016) -
MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022)